Osteoporosis Treatment Market, By Drug Type (Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators, Parathyroid Hormone-Related Protein Analog, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024

Code : CMI1096

Pages :165

Formats :

Excel and PDF

Industry : Pharmaceutical

Osteoporosis Treatment Market Size and Trends

Global osteoporosis treatment market is estimated to be valued at USD 14.91 Bn in 2024 and is expected to reach USD 19.84 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

Osteoporosis Treatment Market Key Factors

To learn more about this report, request sample copy

Introduction of novel therapeutics and self-administrable formulations are expected to boost the market growth. However, availability of generic medicines and patent expiration of blockbuster drugs may hamper the market growth. Emphasis on the development of anabolic drugs, osteoporosis treatment in premenopausal women, and rising awareness regarding the disease are expected to create lucrative opportunities for the market players in the near future.

Increasing Incidence of Osteoporosis

Increasing prevalence and incidence of osteoporosis is expected to drive the market growth during the forecast period. For instance, according to the International Osteoporosis Foundation, osteoporosis causes more than 8.9 billion fractures annually worldwide, resulting in an osteoporosis fracture every 3 seconds.

/p>Increasing Awareness Campaigns

Increasing awareness campaigns is expected to drive the market growth over the forecast period. For instance, in February 2022, the Royal Osteoporosis Society, UK's national charity launched a national campaign to raise awareness about osteoporosis and the importance of bone health among Parliamentarians and NHS leaders.